Cornerstone Wealth Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-637
Closed -$452K 528
2019
Q1
$452K Buy
+637
New +$92.4K 0.05% 287
2018
Q4
Sell
-277,750
Closed -$1.37M 1264
2018
Q3
$1.37M Buy
277,750
+103,727
+60% +$19.1M 0.02% 624
2018
Q2
$1.04M Buy
174,023
+172,492
+11,267% +$27.7M 0.01% 750
2018
Q1
$249K Buy
1,531
+94
+7% +$15.8K 0.05% 325
2017
Q4
$245K Buy
1,437
+70
+5% +$12.6K 0.05% 340
2017
Q3
$276K Sell
1,367
-1
-0.1% -$233 0.06% 299
2017
Q2
$331K Buy
1,368
+179
+15% +$42.1K 0.07% 256
2017
Q1
$285K Buy
+1,189
New +$277K 0.07% 258

Other funds holding AGN

Cornerstone Wealth Management's AGN Position: Q2 2019 in Review

Cornerstone Wealth Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 637 shares — an estimated $452K sold.

Cornerstone Wealth Management first reported a position in AGN in Q1 2017 and held it in 8 quarters. The position peaked at $1.37M in Q3 2018. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Cornerstone Wealth Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Cornerstone Wealth Management sold 637 Allergan plc shares in Q2 2019, an estimated $452K.
  • Cornerstone Wealth Management first reported a position in Allergan plc in Q1 2017 and held it in 8 quarters.
  • Cornerstone Wealth Management's Allergan plc position peaked at $1.37M in Q3 2018.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Cornerstone Wealth Management's 13F filing for Q2 2019, filed 2 Aug 2019.